Panacea Biotec up 5% as Co begins producing Sputnik V vaccine in India

Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund), and Panacea Biotech announced the launch of production of the Russian Sputnik V vaccine against coronavirus

Shares of Panacea Biotec were frozen at 5 per cent upper circuit at Rs 406.10 on the BSE on Tuesday after the company and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), announced the launch of production of the Russian Sputnik V vaccine against coronavirus.

The stock of the biotechnology company was trading close to its 52-week high level of Rs 407.20, touched on April 28, 2021. Till 09:28 am, a combined 143,000 equity shares changed hands and there were pending buy orders for around 960,000 shares on the NSE and BSE.

“The first batch produced